An antipsychotic proves effective in treating schizophrenia when taken orally weekly rather than daily
An oral formulation of risperidone could be administered weekly instead of daily to treat patients with schizophrenia with the same efficacy, according to a phase III clinical trial published in The Lancet Psychiatry. The study included 83 patients in the United States.
0